Principal Scientist, Upstream Development
MSD
Summary
The Biologics Process Research & Development organization within our Company Research Labs is responsible for developing the drug substance manufacturing processes for our Company's biologics pipeline. We work closely with colleagues in Discovery, Pre-clinical and Early Development to rapidly develop manufacturing processes for biotherapeutics and efficiently manufacture material to supply clinical trials. We are also responsible for commercial process development and development and implementation of new manufacturing technologies.
Job description
We are seeking a highly motivated and experienced individual to join our Upstream Development Department as a Principal Scientist. In this role, the successful candidate will work closely with scientists in the Upstream Development Department to develop and refine technical strategy related to next generation processing for assets in early- and late-stage clinical development.
Job Responsibilities
- Leading biologic upstream process development for first-in-human and commercial processes by efficiently developing high yield, robust and scalable cell culture processes.
- Providing technical direction for process development, characterization, commercialization, and regulatory filing activities to ensure a smooth and clear path to successful PPQs and BLAs for our company pipeline.
- Advancing upstream platform process technical strategy and championing creative process improvement initiatives.
- Initiating new collaborations to assess new technologies and industry strategies with relevance to our Company.
- Collaborating with academia, industry partners, and vendors to drive development, innovation and adoption of new process technologies with broad impact to projects or platform.
- Keeping up to date with the external patent and literature environment; actively presents and publishes externally and pursues patenting strategies.
- Supervising, coaching and educating junior scientists.
Minimum Education Required
Ph.D. with 8+ years of industry experience, Master with 10+ years industry experience, bachelor's with 14+ years industry in Chemical Engineering, Bioengineering, Biochemistry or a related field.
Required Experience and Skills
- Proven record of accomplishments in upstream process and technology development with a strong scientific publication and presentation track record.
- Experience in CHO fed-batch cell culture and a working understanding of downstream & analytics.
- Understanding and hands-on experience on cell culture bioreactors including microbioreactors, bench-scale and pilot-scale bioreactors, and scaleup/tech transfer activities.
- Working knowledge of cell culture media, CHO cell biology and metabolism, DOE statistics and computational fluid dynamics.
- Ability to direct the planning, execution, analysis, and documentation of all stages of cell culture process development.
- Ability to work in a matrixed team environment and collaborate with both internal and external partners including vendors.
- Knowledge of biologics CMC development cycle.
- Demonstrated ability for taking initiative, creativity, and innovation in problem solving.
- Demonstrated ability to develop staff to maximize utilization of talent and actively guides career development; builds strong and collaborative teams.
Preferred Experience and Skills
- Experience with state-of-the-art cell culture processes including intensified inoculum and perfusion process development.
- Experience with early- and late-stage commercial process development, technology transfer, scale-down model qualification and process characterization.
- Experience with high throughput microbioreactor systems, and advanced in situ analytics for process monitoring and control.
- Expertise in media development, media/solution chemistry.
- Background in data science approaches related to cell culture and predictive modeling e.g., metabolic flux analysis (MFA), omics, machine learning; experience integrating PAT efforts and computational fluid dynamics (CFD).
- Experience leading cross functional, program development teams.
Requirements
- Ph.D. with 8+ years of industry experience, Master with 10+ years, or Bachelor's with 14+ years in Chemical Engineering, Bioengineering, Biochemistry or related field
- Proven record of accomplishments in upstream process and technology development with strong scientific publication and presentation track record
- Experience in CHO fed-batch cell culture and working understanding of downstream & analytics
- Hands-on experience with cell culture bioreactors including microbioreactors, bench-scale and pilot-scale bioreactors, and scaleup/tech transfer
- Working knowledge of cell culture media, CHO cell biology and metabolism, DOE statistics and computational fluid dynamics
- Ability to direct planning, execution, analysis, and documentation of all stages of cell culture process development
- Ability to work in a matrixed team environment and collaborate with internal and external partners including vendors
- Knowledge of biologics CMC development cycle
- Demonstrated initiative, creativity, and innovation in problem solving
- Demonstrated ability to develop staff and build strong collaborative teams
- Effective organizational and multi-tasking skills
- Demonstrated excellent scientific leadership
- Superior written and oral communications abilities
- Experience successfully mentoring junior scientists and leading projects
Benefits
- Medical, Dental & Vision
- 401(k) Retirement Benefits
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
MSD, known as Merck Sharp & Dohme outside the United States and Canada, is a global research-intensive biopharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891, the company has established itself as one of the world's leading pharmaceutical corporations with a rich history spanning over 130 years. MSD operates as the international division of Merck & Co., Inc., focusing on the discovery, development, manufacturing, and marketing of innovative medicines, vaccines, biologic therapies, and animal health products. The company's extensive portfolio includes groundbreaking treatments in oncology, infectious diseases, cardiology, diabetes, and vaccines, with notable products such as Keytruda (pembrolizumab) for cancer immunotherapy, Gardasil for HPV prevention, and Januvia for diabetes management. MSD maintains a strong commitment to research and development, investing significantly in scientific innovation to address unmet medical needs worldwide. With approximately 75,000 employees globally, the company operates through four main segments: pharmaceuticals, animal health, healthcare services, and strategic alliances. MSD's mission centers on using leading-edge science to save and improve lives around the world, guided by the principle that medicine is for people, not profits.